doi: 10.1021/jm00224a022.
Potential central nervous system antitumor agents. Aziridinylbenzoquinones. 1
- PMID: 1249812
- DOI: 10.1021/jm00224a022
Item in Clipboard
Potential central nervous system antitumor agents. Aziridinylbenzoquinones. 1
J Med Chem.
1976 Feb.
Abstract
A series of 3,6-substituted 2,5-diaziridinyl-1,4-benzoquinones was prepared as potential CNS antitumor agents. Activity was evaluated in the murine leukemia L1210 system. The diurethane derivative 9 was found to have significant activity in that system as well as in the intraperitoneal P388 and B16 tumor models. Marginal Lewis lung activity was observed. Reproducible activity was seen in the intracerebral L1210 and P388 systems. Multiple cures were observed in the murine ependymoblastoma brain tumor model. The effect of substituent type on aziridinylquinone activity is discussed.
Similar articles
-
Potential central nervous system antitumor agents. Aziridinylbenzoquinones.J Med Chem. 1976 Nov;19(11):1302-8. doi: 10.1021/jm00233a010. J Med Chem. 1976. PMID: 1003407
-
Potential CNS antitumor agents VI: aziridinylbenzoquinones III.J Pharm Sci. 1979 Feb;68(2):185-8. doi: 10.1002/jps.2600680217. J Pharm Sci. 1979. PMID: 423089
-
Potential central nervous system antitumor agents. Hydantoin derivatives.J Med Chem. 1975 Aug;18(8):846-9. doi: 10.1021/jm00242a019. J Med Chem. 1975. PMID: 1159704
-
Interaction of gamma-irradiation with two new antineoplastic agents, aziridinylbenzoquinone (AZQ) and 4'- (acridinylamino)methanesulfon-m-anisidide (AMSA), in murine tumors in vivo.Int J Radiat Oncol Biol Phys. 1979 Sep;5(9):1605-9. doi: 10.1016/0360-3016(79)90782-x. Int J Radiat Oncol Biol Phys. 1979. PMID: 583418 No abstract available.
-
Up-to-date improvements in inorganic ring systems as anticancer agents.Top Curr Chem. 1982;102:1-87. doi: 10.1007/3-540-11345-2_7. Top Curr Chem. 1982. PMID: 6750846 Review. No abstract available.
Cited by
-
A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent adenocarcinoma and adenosquamous carcinoma of the cervix. A Gynecologic Oncology Group study.Invest New Drugs. 1989 Nov;7(4):337-40. doi: 10.1007/BF00173764. Invest New Drugs. 1989. PMID: 2599803
-
A phase I/II study of 24 hour intravenous AZQ in recurrent primary brain tumors.J Neurooncol. 1988 Dec;6(4):319-23. doi: 10.1007/BF00177426. J Neurooncol. 1988. PMID: 3221259
-
Thiol oxidation coupled to DT-diaphorase-catalysed reduction of diaziquone. Reductive and oxidative pathways of diaziquone semiquinone modulated by glutathione and superoxide dismutase.Biochem J. 1992 Sep 1;286 ( Pt 2)(Pt 2):481-90. doi: 10.1042/bj2860481. Biochem J. 1992. PMID: 1530580 Free PMC article.
-
Synthesis of 1,3,4-thiadiazole, 1,3,4-thiadiazine, 1,3,6-thiadiazepane and quinoxaline derivatives from symmetrical dithiobiureas and thioureidoethylthiourea derivatives.Molecules. 2005 Aug 31;10(7):822-32. doi: 10.3390/10070822. Molecules. 2005. PMID: 18007352 Free PMC article.
-
Stability of 2,5-diaziridinyl-3,6-bis(2-hydroxyethylamino)-1,4-benzoquinone (BZQ; NSC 224070) in aqueous solutions by high-performance liquid chromatography.Invest New Drugs. 1985;3(1):43-50. doi: 10.1007/BF00176823. Invest New Drugs. 1985. PMID: 3838738
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources